Literature DB >> 33288901

Ubiquitin-dependent and -independent functions of OTULIN in cell fate control and beyond.

Nadine Weinelt1, Sjoerd J L van Wijk2.   

Abstract

Ubiquitination, and its control by deubiquitinating enzymes (DUBs), mediates protein stability, function, signaling and cell fate. The ovarian tumor (OTU) family DUB OTULIN (FAM105B) exclusively cleaves linear (Met1-linked) poly-ubiquitin chains and plays important roles in auto-immunity, inflammation and infection. OTULIN regulates Met1-linked ubiquitination downstream of tumor necrosis factor receptor 1 (TNFR1), toll-like receptor (TLR) and nucleotide-binding and oligomerization domain-containing protein 2 (NOD2) receptor activation and interacts with the Met1 ubiquitin-specific linear ubiquitin chain assembly complex (LUBAC) E3 ligase. However, despite extensive research efforts, the receptor and cytosolic roles of OTULIN and the distributions of multiple Met1 ubiquitin-associated E3-DUB complexes in the regulation of cell fate still remain controversial and unclear. Apart from that, novel ubiquitin-independent OTULIN functions have emerged highlighting an even more complex role of OTULIN in cellular homeostasis. For example, OTULIN interferes with endosome-to-plasma membrane trafficking and the OTULIN-related pseudo-DUB OTULINL (FAM105A) resides at the endoplasmic reticulum (ER). Here, we discuss how OTULIN contributes to cell fate control and highlight novel ubiquitin-dependent and -independent functions.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33288901      PMCID: PMC7862380          DOI: 10.1038/s41418-020-00675-x

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   12.067


  76 in total

Review 1.  Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions.

Authors:  Koraljka Husnjak; Ivan Dikic
Journal:  Annu Rev Biochem       Date:  2012-04-05       Impact factor: 23.643

Review 2.  Ubiquitin chain diversity at a glance.

Authors:  Masato Akutsu; Ivan Dikic; Anja Bremm
Journal:  J Cell Sci       Date:  2016-02-15       Impact factor: 5.285

3.  Linear ubiquitination prevents inflammation and regulates immune signalling.

Authors:  Björn Gerlach; Stefanie M Cordier; Anna C Schmukle; Christoph H Emmerich; Eva Rieser; Tobias L Haas; Andrew I Webb; James A Rickard; Holly Anderton; Wendy W-L Wong; Ueli Nachbur; Lahiru Gangoda; Uwe Warnken; Anthony W Purcell; John Silke; Henning Walczak
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

4.  SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis.

Authors:  Fumiyo Ikeda; Yonathan Lissanu Deribe; Sigrid S Skånland; Benjamin Stieglitz; Caroline Grabbe; Mirita Franz-Wachtel; Sjoerd J L van Wijk; Panchali Goswami; Vanja Nagy; Janos Terzic; Fuminori Tokunaga; Ariadne Androulidaki; Tomoko Nakagawa; Manolis Pasparakis; Kazuhiro Iwai; John P Sundberg; Liliana Schaefer; Katrin Rittinger; Boris Macek; Ivan Dikic
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

5.  Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease.

Authors:  Qing Zhou; Xiaomin Yu; Erkan Demirkaya; Natalie Deuitch; Deborah Stone; Wanxia Li Tsai; Hye Sun Kuehn; Hongying Wang; Dan Yang; Yong Hwan Park; Amanda K Ombrello; Mary Blake; Tina Romeo; Elaine F Remmers; Jae Jin Chae; James C Mullikin; Ferhat Güzel; Joshua D Milner; Manfred Boehm; Sergio D Rosenzweig; Massimo Gadina; Steven B Welch; Seza Özen; Rezan Topaloglu; Mario Abinun; Daniel L Kastner; Ivona Aksentijevich
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-24       Impact factor: 11.205

Review 6.  Breaking the chains: deubiquitylating enzyme specificity begets function.

Authors:  Michael J Clague; Sylvie Urbé; David Komander
Journal:  Nat Rev Mol Cell Biol       Date:  2019-06       Impact factor: 94.444

7.  Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia.

Authors:  Bertrand Boisson; Emmanuel Laplantine; Kerry Dobbs; Aurélie Cobat; Nadine Tarantino; Melissa Hazen; Hart G W Lidov; Gregory Hopkins; Likun Du; Aziz Belkadi; Maya Chrabieh; Yuval Itan; Capucine Picard; Jean-Christophe Fournet; Hermann Eibel; Erdyni Tsitsikov; Sung-Yun Pai; Laurent Abel; Waleed Al-Herz; Jean-Laurent Casanova; Alain Israel; Luigi D Notarangelo
Journal:  J Exp Med       Date:  2015-05-25       Impact factor: 14.307

8.  OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death.

Authors:  Rune Busk Damgaard; Paul R Elliott; Kirby N Swatek; Eamonn R Maher; Polina Stepensky; Orly Elpeleg; David Komander; Yackov Berkun
Journal:  EMBO Mol Med       Date:  2019-03       Impact factor: 12.137

9.  Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency.

Authors:  Bertrand Boisson; Emmanuel Laplantine; Carolina Prando; Silvia Giliani; Elisabeth Israelsson; Zhaohui Xu; Avinash Abhyankar; Laura Israël; Giraldina Trevejo-Nunez; Dusan Bogunovic; Alma-Martina Cepika; Donna MacDuff; Maya Chrabieh; Marjorie Hubeau; Fanny Bajolle; Marianne Debré; Evelina Mazzolari; Donatella Vairo; Fabrice Agou; Herbert W Virgin; Xavier Bossuyt; Caroline Rambaud; Fabio Facchetti; Damien Bonnet; Pierre Quartier; Jean-Christophe Fournet; Virginia Pascual; Damien Chaussabel; Luigi D Notarangelo; Anne Puel; Alain Israël; Jean-Laurent Casanova; Capucine Picard
Journal:  Nat Immunol       Date:  2012-10-28       Impact factor: 25.606

10.  The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity.

Authors:  Rune Busk Damgaard; Jennifer A Walker; Paola Marco-Casanova; Neil V Morgan; Hannah L Titheradge; Paul R Elliott; Duncan McHale; Eamonn R Maher; Andrew N J McKenzie; David Komander
Journal:  Cell       Date:  2016-08-11       Impact factor: 41.582

View more
  8 in total

Review 1.  Molecular Mechanisms of DUBs Regulation in Signaling and Disease.

Authors:  Ying Li; David Reverter
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

Review 2.  Deubiquitinases: Modulators of Different Types of Regulated Cell Death.

Authors:  Choong-Sil Lee; Seungyeon Kim; Gyuho Hwang; Jaewhan Song
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

Review 3.  Emerging roles of the HECT-type E3 ubiquitin ligases in hematological malignancies.

Authors:  Vincenza Simona Delvecchio; Claudia Fierro; Sara Giovannini; Gerry Melino; Francesca Bernassola
Journal:  Discov Oncol       Date:  2021-10-08

Review 4.  The ubiquitin ligation machinery in the defense against bacterial pathogens.

Authors:  Ishita Tripathi-Giesgen; Christian Behrends; Arno F Alpi
Journal:  EMBO Rep       Date:  2021-09-13       Impact factor: 8.807

Review 5.  LUBAC: a new player in polyglucosan body disease.

Authors:  Andrew Aboujaoude; Berge Minassian; Sharmistha Mitra
Journal:  Biochem Soc Trans       Date:  2021-11-01       Impact factor: 5.407

6.  Compound heterozygous variants in OTULIN are associated with fulminant atypical late-onset ORAS.

Authors:  Catharina Schuetz; Pamela Fischer-Posovszky; Klaus-Michael Debatin; Julia Zinngrebe; Barbara Moepps; Thomas Monecke; Peter Gierschik; Ferdinand Schlichtig; Thomas F E Barth; Gudrun Strauß; Elena Boldrin; Carsten Posovszky; Ansgar Schulz; Ortraud Beringer; Eva Rieser; Eva-Maria Jacobsen; Myriam Ricarda Lorenz; Klaus Schwarz; Ulrich Pannicke; Henning Walczak; Dierk Niessing
Journal:  EMBO Mol Med       Date:  2022-02-16       Impact factor: 14.260

7.  Reciprocal interplay between OTULIN-LUBAC determines genotoxic and inflammatory NF-κB signal responses.

Authors:  Mingqi Li; Ling Li; Sarah Asemota; David Kakhniashvili; Ramesh Narayanan; Xusheng Wang; Francesca-Fang Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-08       Impact factor: 12.779

8.  Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation.

Authors:  Adnan Erol
Journal:  Cancer Manag Res       Date:  2022-08-05       Impact factor: 3.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.